Trade Talks, Europe on Mend, Gender Discrimination: Eco Day
(Bloomberg) -- Welcome to Tuesday, Asia. Here's the latest news and analysis from Bloomberg Economics to help get your day started:
- China has offered the U.S. some “very attractive numbers” for purchases of farm goods as part of “dynamic” trade talks, but there are still concerns over areas such as biotechnology, according to U.S. Agriculture Secretary Sonny Perdue
- German industry continued to stumble, suggesting the economy is unlikely to have enjoyed a long-awaited turnaround at the start of 2019. France's high and rising private debt burden has worried regulators enough that they are forcing banks to put aside more capital. Europe's economy hasn't given investors much cheer over the past year, but some see positive surprises in store
- Almost half of female economists have experienced gender discrimination, according to an American Economic Association survey that also included reports of assault and harassment
- Princeton University economist Alan Krueger, who served as chairman of President Barack Obama's Council of Economic Advisers and was one of the profession's top experts on the labor market, has died at the age of 58
- Sentiment among U.S. homebuilders held steady in March, sustaining a rebound from a recent three-year low on improvement in sales and a brighter outlook for the next six months
- Canada's next budget will look very familiar, with Justin Trudeau set to spend much of a revenue windfall and continued red ink in his government's books.
To contact the reporter on this story: Michael Heath in Sydney at mheath1@bloomberg.net
To contact the editors responsible for this story: Nasreen Seria at nseria@bloomberg.net, Matthew Brockett
©2019 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.